233 related articles for article (PubMed ID: 22207051)
21. Can Metastatic Lymph node ratio be used as an independent prognostic factor in Carcinoma tongue?
Bharath VM; Balagopal PG; Nebu AG; Jayasudha AV; Iqbal Ahmed M; Sebastian P
Gulf J Oncolog; 2018 Sep; 1(28):6-10. PubMed ID: 30344127
[TBL] [Abstract][Full Text] [Related]
22. Lymph Node Ratio in Sentinel Lymph Node Biopsy Era: Are We Losing Prognostic Information?
Quintyne KI; Woulfe B; Coffey JC; Merrigan A; Gupta RK
Clin Breast Cancer; 2017 Apr; 17(2):117-126. PubMed ID: 27592541
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of lymph node ratio in node-positive breast cancer: a Dutch nationwide population-based study.
Dings PJ; Elferink MA; Strobbe LJ; de Wilt JH
Ann Surg Oncol; 2013 Aug; 20(8):2607-14. PubMed ID: 23536053
[TBL] [Abstract][Full Text] [Related]
24. Evaluation on prognostic efficacy of lymph nodes ratio (LNR) and log odds of positive lymph nodes (LODDS) in complicated colon cancer: the first study in emergency surgery.
Occhionorelli S; Andreotti D; Vallese P; Morganti L; Lacavalla D; Forini E; Pascale G
World J Surg Oncol; 2018 Sep; 16(1):186. PubMed ID: 30213260
[TBL] [Abstract][Full Text] [Related]
25. Predictive Value of the Number of Harvested Lymph Nodes and Cut-Off for Lymph Node Ratio in the Prognosis of Stage II and III Colorectal Cancer Patients.
Li Destri G; Barchitta M; Pesce A; Latteri S; Bosco D; Di Cataldo A; Agodi A; Puleo S
J Invest Surg; 2019 Jan; 32(1):1-7. PubMed ID: 28972442
[TBL] [Abstract][Full Text] [Related]
26. Ratio and log odds of positive lymph nodes in breast cancer patients with mastectomy.
Chen LJ; Chung KP; Chang YJ; Chang YJ
Surg Oncol; 2015 Sep; 24(3):239-47. PubMed ID: 26055316
[TBL] [Abstract][Full Text] [Related]
27. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of residual nodal burden using lymph node ratio in locally advanced breast cancer after neoadjuvant chemotherapy.
Agarwal R; Philip A; Pavithran K; Rajanbabu A; Goel G; Vijaykumar DK
Indian J Cancer; 2019; 56(3):228-235. PubMed ID: 31389386
[TBL] [Abstract][Full Text] [Related]
29. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer.
Sosa JA; Diener-West M; Gusev Y; Choti MA; Lange JR; Dooley WC; Zeiger MA
Ann Surg Oncol; 1998 Mar; 5(2):140-9. PubMed ID: 9527267
[TBL] [Abstract][Full Text] [Related]
30. Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined.
Jiang K; Zhu Y; Liu Y; Ye Y; Xie Q; Yang X; Wang S
Tumour Biol; 2014 Nov; 35(11):11685-90. PubMed ID: 25139098
[TBL] [Abstract][Full Text] [Related]
31. "Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients".
van Wely BJ; van den Wildenberg FJ; Gobardhan P; van Dalen T; Borel Rinkes IH; Theunissen EB; Wijsman JH; Ernst M; van der Pol CC; Madsen EV; Vles WJ; Wauters CA; de Wilt JH; Strobbe LJ
Eur J Surg Oncol; 2012 Oct; 38(10):925-31. PubMed ID: 22633152
[TBL] [Abstract][Full Text] [Related]
32. Lymph node ratio should be considered for incorporation into staging for breast cancer.
Chagpar AB; Camp RL; Rimm DL
Ann Surg Oncol; 2011 Oct; 18(11):3143-8. PubMed ID: 21847696
[TBL] [Abstract][Full Text] [Related]
33. The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer.
He M; Zhang JX; Jiang YZ; Chen YL; Yang HY; Tang LC; Shao ZM; Di GH
Oncotarget; 2017 Jul; 8(27):44870-44880. PubMed ID: 28496004
[TBL] [Abstract][Full Text] [Related]
34. Nodal Ratio as a Prognostic Factor in Patients with Four or More Positive Axillary Nodes Treated with Breast-conserving Therapy and Regional Nodal Irradiation.
Iatì G; Pontoriero A; Mondello S; Santacaterina A; Platania A; Frosina P; Raso MM; Aiello D; Arcudi A; Arena G; Marino G; Mazzei M; Rifatto C; Risoleti E; Runco R; Sansotta G; Delia P; Sindoni A; Pergolizzi S
Anticancer Res; 2016 Jul; 36(7):3549-54. PubMed ID: 27354622
[TBL] [Abstract][Full Text] [Related]
35. Regional Lymph Nodes Status and Ratio of Metastatic to Examined Lymph Nodes Correlate with Survival in Stage IV Colorectal Cancer.
Ahmed S; Leis A; Chandra-Kanthan S; Fields A; Zaidi A; Abbas T; Le D; Reeder B; Pahwa P
Ann Surg Oncol; 2016 Jul; 23(7):2287-94. PubMed ID: 27016291
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of a nomogram for predicting survival on the base of modified lymph node ratio in breast cancer patients.
Wen J; Yang Y; Liu P; Ye F; Tang H; Huang X; Zhong S; Xie X
Breast; 2017 Jun; 33():14-22. PubMed ID: 28259045
[TBL] [Abstract][Full Text] [Related]
37. Impact of Lymph Node Ratio and Adjuvant Therapy in Node-Positive Endometrioid Endometrial Cancer.
Fleming ND; Soliman PT; Westin SN; dos Reis R; Munsell M; Klopp AH; Frumovitz M; Nick AM; Schmeler K; Ramirez PT
Int J Gynecol Cancer; 2015 Oct; 25(8):1437-44. PubMed ID: 26332387
[TBL] [Abstract][Full Text] [Related]
38. Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio.
Birnbaum DJ; Viganò L; Russolillo N; Langella S; Ferrero A; Capussotti L
Ann Surg Oncol; 2015 Mar; 22(3):811-8. PubMed ID: 25201500
[TBL] [Abstract][Full Text] [Related]
39. Additional Prognostic Value of Lymph Node Ratio (LNR) and Number of Negative Lymph Nodes (NLNs) in Chinese Patients with Triple Negative Breast Cancer.
Wang QX; Cai YF; Chen YY; Zhang W; Jin WX; Chen ED; Zhang XH; Li Q
Ann Clin Lab Sci; 2017 Jan; 47(1):68-75. PubMed ID: 28249920
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of the lymph node ratio in stage IV colorectal cancer patients who have undergone curative resection.
Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
Ann Surg Oncol; 2015 May; 22(5):1513-9. PubMed ID: 25398278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
